Shots: The EC’s approval is based on PLUTO study assessing Benlysta (10 mg/kg IV) + SoC vs PBO + SoC in 93 children aged 5 – 11yrs. and 12 – […]readmore
Tags : First Biologic
Shots: The US FDA’s approval follows the open-label study evaluating PK/PD and long-term safety of Nucala (40mg, SC) in children with severe eosinophilic asthma aged 6 to 11yrs. The approval […]readmore